| reciprocal meiotic recombination | GO:0007131 | 19 | 1.000 | |
| germarium derived oocyte differentiation | GO:0030706 | 29 | 0.999 | |
| germarium derived egg chamber formation | GO:0007293 | 101 | 0.999 | |
| chorion containing eggshell formation | GO:0007304 | 105 | 0.998 | |
| karyosome formation | GO:0030717 | 22 | 0.993 | |
| polarity specification of dorsal ventral axis | GO:0009951 | 6 | 0.991 | |
| germarium derived oocyte fate determination | GO:0007294 | 26 | 0.991 | |
| reciprocal dna recombination | GO:0035825 | 19 | 0.990 | |
| dna recombination | GO:0006310 | 32 | 0.990 | Human |
| recombinational repair | GO:0000725 | 13 | 0.985 | Human |
| eggshell chorion assembly | GO:0007306 | 66 | 0.979 | |
| meiosis i | GO:0007127 | 59 | 0.974 | |
| dorsal appendage formation | GO:0046843 | 47 | 0.965 | |
| columnar cuboidal epithelial cell differentiation | GO:0002065 | 256 | 0.960 | |
| eggshell formation | GO:0030703 | 105 | 0.957 | |
| polarity specification of anterior posterior axis | GO:0009949 | 5 | 0.955 | |
| meiotic chromosome segregation | GO:0045132 | 59 | 0.955 | |
| organelle fission | GO:0048285 | 340 | 0.955 | |
| ovarian follicle cell development | GO:0030707 | 248 | 0.950 | |
| meiotic cell cycle | GO:0051321 | 171 | 0.944 | |
| meiotic cell cycle process | GO:1903046 | 132 | 0.939 | |
| meiotic nuclear division | GO:0007126 | 151 | 0.935 | |
| double strand break repair via homologous recombination | GO:0000724 | 13 | 0.919 | Human |
| oocyte differentiation | GO:0009994 | 145 | 0.901 | |
| dna metabolic process | GO:0006259 | 227 | 0.890 | Human |
| chromosome organization | GO:0051276 | 360 | 0.889 | |
| dna damage checkpoint | GO:0000077 | 78 | 0.877 | |
| columnar cuboidal epithelial cell development | GO:0002066 | 249 | 0.876 | |
| cellular response to dna damage stimulus | GO:0006974 | 223 | 0.818 | Human |
| dorsal ventral axis specification | GO:0009950 | 66 | 0.816 | |
| cell cycle checkpoint | GO:0000075 | 95 | 0.809 | Human |
| chromosome segregation | GO:0007059 | 157 | 0.808 | |
| dorsal ventral pattern formation | GO:0009953 | 133 | 0.765 | |
| specification of axis polarity | GO:0065001 | 6 | 0.728 | |
| regulation of mitotic cell cycle phase transition | GO:1901990 | 130 | 0.728 | Human |
| dna geometric change | GO:0032392 | 16 | 0.722 | |
| dna integrity checkpoint | GO:0031570 | 81 | 0.718 | |
| double strand break repair via synthesis dependent strand annealing | GO:0045003 | 6 | 0.710 | |
| g2 dna damage checkpoint | GO:0031572 | 69 | 0.709 | |
| resolution of meiotic recombination intermediates | GO:0000712 | 6 | 0.691 | |
| axis specification | GO:0009798 | 167 | 0.678 | |
| nuclear division | GO:0000280 | 332 | 0.674 | |
| mitotic cell cycle phase transition | GO:0044772 | 138 | 0.665 | |
| epithelial cell development | GO:0002064 | 274 | 0.657 | |
| oocyte fate determination | GO:0030716 | 27 | 0.649 | |
| double strand break repair | GO:0006302 | 26 | 0.635 | Human |
| regulation of cell cycle process | GO:0010564 | 181 | 0.620 | Human |
| regulation of cell cycle phase transition | GO:1901987 | 130 | 0.619 | Human |
| regulation of mitotic cell cycle | GO:0007346 | 190 | 0.604 | Human |
| nucleotide excision repair | GO:0006289 | 8 | 0.582 | |
| oocyte localization involved in germarium derived egg chamber formation | GO:0030720 | 12 | 0.525 | |
| mitotic dna damage checkpoint | GO:0044773 | 74 | 0.505 | |
| oocyte nucleus localization involved in oocyte dorsal ventral axis specification | GO:0051663 | 12 | 0.502 | |
| dna repair | GO:0006281 | 54 | 0.493 | Human |
| cellular component assembly involved in morphogenesis | GO:0010927 | 151 | 0.475 | |
| oocyte dorsal ventral axis specification | GO:0007310 | 34 | 0.466 | |
| aromatic compound catabolic process | GO:0019439 | 166 | 0.462 | Human |
| positive regulation of mitotic cell cycle phase transition | GO:1901992 | 20 | 0.455 | |
| female meiosis chromosome segregation | GO:0016321 | 33 | 0.452 | |
| microtubule organizing center organization | GO:0031023 | 168 | 0.426 | Human |
| negative regulation of cell cycle phase transition | GO:1901988 | 103 | 0.390 | Human |
| cell cycle phase transition | GO:0044770 | 140 | 0.386 | |
| double strand break repair via nonhomologous end joining | GO:0006303 | 5 | 0.380 | |
| female meiotic division | GO:0007143 | 70 | 0.374 | |
| regionalization | GO:0003002 | 416 | 0.358 | |
| heterocycle catabolic process | GO:0046700 | 166 | 0.357 | Human |
| oocyte development | GO:0048599 | 124 | 0.330 | |
| dna duplex unwinding | GO:0032508 | 16 | 0.328 | |
| oocyte axis specification | GO:0007309 | 108 | 0.328 | |
| anterior posterior pattern specification | GO:0009952 | 136 | 0.326 | |
| organic cyclic compound catabolic process | GO:1901361 | 168 | 0.315 | Human |
| regulation of cell cycle | GO:0051726 | 291 | 0.315 | Human |
| dna synthesis involved in dna repair | GO:0000731 | 5 | 0.308 | |
| nucleobase containing compound catabolic process | GO:0034655 | 165 | 0.303 | Human |
| male gamete generation | GO:0048232 | 201 | 0.302 | |
| anterior posterior axis specification | GO:0009948 | 109 | 0.287 | |
| spermatogenesis | GO:0007283 | 200 | 0.285 | |
| oocyte anterior posterior axis specification | GO:0007314 | 72 | 0.283 | |
| cell fate determination | GO:0001709 | 91 | 0.282 | |
| sister chromatid segregation | GO:0000819 | 92 | 0.273 | |
| non recombinational repair | GO:0000726 | 7 | 0.273 | |
| organic substance catabolic process | GO:1901575 | 308 | 0.262 | Human |
| mitotic dna integrity checkpoint | GO:0044774 | 75 | 0.260 | |
| cellular catabolic process | GO:0044248 | 372 | 0.253 | Human |
| cellular nitrogen compound catabolic process | GO:0044270 | 165 | 0.243 | Human |
| response to abiotic stimulus | GO:0009628 | 341 | 0.241 | |
| actin cytoskeleton organization | GO:0030036 | 206 | 0.221 | |
| male meiosis | GO:0007140 | 52 | 0.219 | |
| chromosome separation | GO:0051304 | 42 | 0.218 | |
| negative regulation of cell cycle | GO:0045786 | 116 | 0.207 | Human |
| cellular macromolecule catabolic process | GO:0044265 | 136 | 0.201 | Human |
| gene silencing | GO:0016458 | 138 | 0.197 | |
| telomere maintenance via recombination | GO:0000722 | 1 | 0.191 | |
| positive regulation of macromolecule biosynthetic process | GO:0010557 | 283 | 0.187 | |
| macromolecule catabolic process | GO:0009057 | 161 | 0.182 | Human |
| mitotic g2 m transition checkpoint | GO:0044818 | 70 | 0.177 | |
| epithelial cell differentiation | GO:0030855 | 322 | 0.169 | |
| positive regulation of mitotic cell cycle | GO:0045931 | 34 | 0.169 | Human |
| oocyte construction | GO:0007308 | 112 | 0.165 | |
| cellular macromolecule localization | GO:0070727 | 220 | 0.154 | |
| purine ribonucleoside monophosphate metabolic process | GO:0009167 | 50 | 0.151 | |
| mitotic g2 dna damage checkpoint | GO:0007095 | 69 | 0.150 | |
| cell division | GO:0051301 | 248 | 0.149 | |
| maternal determination of anterior posterior axis embryo | GO:0008358 | 74 | 0.142 | |
| g2 m transition of mitotic cell cycle | GO:0000086 | 19 | 0.132 | |
| dna catabolic process | GO:0006308 | 16 | 0.132 | Human |
| small molecule metabolic process | GO:0044281 | 305 | 0.128 | |
| rna localization | GO:0006403 | 115 | 0.127 | |
| transcription from rna polymerase ii promoter | GO:0006366 | 368 | 0.127 | |
| negative regulation of mitotic cell cycle phase transition | GO:1901991 | 103 | 0.124 | Human |
| response to organic substance | GO:0010033 | 284 | 0.112 | |
| response to organonitrogen compound | GO:0010243 | 75 | 0.109 | |
| intracellular mrna localization | GO:0008298 | 66 | 0.105 | |
| dorsal ventral axis specification ovarian follicular epithelium | GO:0008069 | 13 | 0.100 | |
| regulation of gene expression epigenetic | GO:0040029 | 128 | 0.100 | |
| regulation of dna metabolic process | GO:0051052 | 34 | 0.098 | |
| regulation of protein metabolic process | GO:0051246 | 256 | 0.093 | Human |
| mitotic cell cycle checkpoint | GO:0007093 | 88 | 0.088 | Human |
| mitotic sister chromatid segregation | GO:0000070 | 87 | 0.087 | |
| positive regulation of dna endoreduplication | GO:0032877 | 4 | 0.084 | |
| regulation of transcription from rna polymerase ii promoter | GO:0006357 | 378 | 0.082 | |
| apoptotic process | GO:0006915 | 159 | 0.082 | |
| spindle organization | GO:0007051 | 253 | 0.082 | |
| mitotic recombination | GO:0006312 | 2 | 0.080 | Human |
| negative regulation of oskar mrna translation | GO:0007319 | 5 | 0.079 | |
| positive regulation of cell cycle process | GO:0090068 | 28 | 0.077 | Human |
| negative regulation of transposition | GO:0010529 | 12 | 0.076 | |
| positive regulation of cellular biosynthetic process | GO:0031328 | 316 | 0.075 | |
| negative regulation of mitotic cell cycle | GO:0045930 | 109 | 0.074 | Human |
| pole plasm assembly | GO:0007315 | 61 | 0.073 | |
| negative regulation of signal transduction | GO:0009968 | 206 | 0.071 | |
| cell cycle dna replication | GO:0044786 | 23 | 0.070 | |
| response to light stimulus | GO:0009416 | 124 | 0.069 | |
| negative regulation of cell cycle process | GO:0010948 | 109 | 0.069 | Human |
| catabolic process | GO:0009056 | 409 | 0.066 | Human |
| negative regulation of nucleic acid templated transcription | GO:1903507 | 240 | 0.066 | |
| gene silencing by rna | GO:0031047 | 57 | 0.065 | |
| negative regulation of cellular component organization | GO:0051129 | 108 | 0.064 | Human |
| ras protein signal transduction | GO:0007265 | 88 | 0.064 | |
| ovarian fusome organization | GO:0030723 | 11 | 0.063 | |
| meiotic chromosome separation | GO:0051307 | 8 | 0.062 | |
| response to caffeine | GO:0031000 | 12 | 0.062 | |
| embryonic pattern specification | GO:0009880 | 174 | 0.061 | |
| eggshell chorion gene amplification | GO:0007307 | 9 | 0.060 | |
| positive regulation of macromolecule metabolic process | GO:0010604 | 405 | 0.060 | |
| positive regulation of cell cycle | GO:0045787 | 43 | 0.060 | Human |
| ribose phosphate metabolic process | GO:0019693 | 145 | 0.059 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 174 | 0.059 | |
| cell maturation | GO:0048469 | 144 | 0.058 | |
| chorion containing eggshell pattern formation | GO:0030381 | 11 | 0.058 | |
| pirna metabolic process | GO:0034587 | 10 | 0.055 | |
| ncrna 3 end processing | GO:0043628 | 17 | 0.055 | |
| death | GO:0016265 | 284 | 0.053 | |
| cytoplasmic transport nurse cell to oocyte | GO:0007303 | 12 | 0.053 | |
| regulation of response to stress | GO:0080134 | 200 | 0.052 | |
| mitotic nuclear division | GO:0007067 | 213 | 0.052 | |
| cell cycle g2 m phase transition | GO:0044839 | 22 | 0.052 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 108 | 0.050 | |
| negative regulation of rna metabolic process | GO:0051253 | 251 | 0.049 | |
| positive regulation of biosynthetic process | GO:0009891 | 316 | 0.049 | |
| organonitrogen compound metabolic process | GO:1901564 | 318 | 0.049 | |
| response to radiation | GO:0009314 | 155 | 0.048 | |
| dna conformation change | GO:0071103 | 105 | 0.048 | |
| phosphorylation | GO:0016310 | 294 | 0.047 | |
| actin filament based process | GO:0030029 | 220 | 0.047 | |
| purine ribonucleoside catabolic process | GO:0046130 | 112 | 0.047 | |
| actin filament organization | GO:0007015 | 126 | 0.046 | |
| sister chromatid cohesion | GO:0007062 | 18 | 0.045 | |
| negative regulation of rna biosynthetic process | GO:1902679 | 240 | 0.045 | |
| programmed cell death | GO:0012501 | 257 | 0.044 | |
| ribonucleoside catabolic process | GO:0042454 | 112 | 0.043 | |
| purine ribonucleoside metabolic process | GO:0046128 | 127 | 0.043 | |
| regulation of small gtpase mediated signal transduction | GO:0051056 | 93 | 0.042 | |
| ribonucleoside metabolic process | GO:0009119 | 127 | 0.042 | |
| regulation of pole plasm oskar mrna localization | GO:0007317 | 27 | 0.040 | |
| negative regulation of cellular metabolic process | GO:0031324 | 382 | 0.040 | Human |
| nucleoside phosphate catabolic process | GO:1901292 | 110 | 0.039 | |
| body morphogenesis | GO:0010171 | 2 | 0.037 | |
| regulation of catabolic process | GO:0009894 | 170 | 0.037 | Human |
| regulation of phosphorus metabolic process | GO:0051174 | 210 | 0.036 | |
| developmental maturation | GO:0021700 | 172 | 0.035 | |
| single organism biosynthetic process | GO:0044711 | 206 | 0.035 | |
| positive regulation of nitrogen compound metabolic process | GO:0051173 | 354 | 0.035 | |
| signal transduction by phosphorylation | GO:0023014 | 107 | 0.034 | |
| single organism cellular localization | GO:1902580 | 180 | 0.034 | |
| blastoderm segmentation | GO:0007350 | 159 | 0.033 | |
| dna double strand break processing | GO:0000729 | 3 | 0.033 | |
| oocyte maturation | GO:0001556 | 3 | 0.033 | |
| endocytosis | GO:0006897 | 310 | 0.032 | |
| nucleoside metabolic process | GO:0009116 | 127 | 0.032 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 119 | 0.032 | |
| targeting of mrna for destruction involved in rna interference | GO:0030423 | 4 | 0.031 | |
| positive regulation of cellular component organization | GO:0051130 | 156 | 0.031 | |
| purine containing compound catabolic process | GO:0072523 | 112 | 0.031 | |
| response to organic cyclic compound | GO:0014070 | 89 | 0.031 | |
| mrna processing | GO:0006397 | 104 | 0.031 | |
| ribonucleoside monophosphate metabolic process | GO:0009161 | 51 | 0.031 | |
| purine containing compound metabolic process | GO:0072521 | 155 | 0.031 | |
| meiotic sister chromatid segregation | GO:0045144 | 6 | 0.030 | |
| cellular macromolecular complex assembly | GO:0034622 | 153 | 0.030 | |
| rna polymerase ii transcriptional preinitiation complex assembly | GO:0051123 | 20 | 0.030 | |
| chromatin organization | GO:0006325 | 207 | 0.029 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 108 | 0.029 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 116 | 0.028 | |
| organelle assembly | GO:0070925 | 198 | 0.028 | |
| chromatin modification | GO:0016568 | 147 | 0.028 | |
| positive regulation of signal transduction | GO:0009967 | 223 | 0.027 | |
| positive regulation of signaling | GO:0023056 | 243 | 0.027 | |
| dna amplification | GO:0006277 | 11 | 0.027 | |
| carbohydrate derivative metabolic process | GO:1901135 | 217 | 0.027 | |
| negative regulation of cellular biosynthetic process | GO:0031327 | 277 | 0.026 | |
| small gtpase mediated signal transduction | GO:0007264 | 88 | 0.026 | |
| protein modification process | GO:0036211 | 438 | 0.026 | |
| single organism catabolic process | GO:0044712 | 228 | 0.026 | |
| vesicle mediated transport | GO:0016192 | 381 | 0.026 | |
| posttranscriptional gene silencing | GO:0016441 | 46 | 0.026 | |
| nucleus localization | GO:0051647 | 34 | 0.026 | |
| positive regulation of catabolic process | GO:0009896 | 105 | 0.026 | |
| nucleoside phosphate metabolic process | GO:0006753 | 162 | 0.025 | |
| enzyme linked receptor protein signaling pathway | GO:0007167 | 179 | 0.025 | |
| cell death | GO:0008219 | 279 | 0.025 | |
| response to camptothecin | GO:1901563 | 2 | 0.025 | |
| chromatin remodeling | GO:0006338 | 72 | 0.025 | |
| cytoplasm organization | GO:0007028 | 64 | 0.025 | |
| organophosphate metabolic process | GO:0019637 | 195 | 0.025 | |
| response to alkaloid | GO:0043279 | 26 | 0.025 | |
| oocyte microtubule cytoskeleton organization | GO:0016325 | 35 | 0.024 | |
| negative regulation of cell communication | GO:0010648 | 223 | 0.024 | |
| protein phosphorylation | GO:0006468 | 169 | 0.024 | |
| establishment of oocyte nucleus localization involved in oocyte dorsal ventral axis specification | GO:0030722 | 6 | 0.024 | |
| response to nitrogen compound | GO:1901698 | 90 | 0.024 | |
| positive regulation of transcription from rna polymerase ii promoter | GO:0045944 | 204 | 0.024 | |
| purine nucleoside monophosphate catabolic process | GO:0009128 | 38 | 0.023 | |
| nuclear dna replication | GO:0033260 | 1 | 0.023 | |
| purine nucleoside metabolic process | GO:0042278 | 127 | 0.023 | |
| purine nucleoside monophosphate metabolic process | GO:0009126 | 50 | 0.023 | |
| medium chain fatty acid metabolic process | GO:0051791 | 1 | 0.023 | |
| regulation of meiosis | GO:0040020 | 3 | 0.023 | |
| protein dna complex subunit organization | GO:0071824 | 86 | 0.022 | |
| regulation of organelle organization | GO:0033043 | 196 | 0.022 | Human |
| positive regulation of response to stimulus | GO:0048584 | 323 | 0.022 | |
| positive regulation of nuclear transcribed mrna poly a tail shortening | GO:0060213 | 4 | 0.022 | |
| negative regulation of erk1 and erk2 cascade | GO:0070373 | 3 | 0.022 | |
| response to ionizing radiation | GO:0010212 | 32 | 0.022 | |
| regulation of nuclear division | GO:0051783 | 58 | 0.022 | Human |
| purine nucleotide metabolic process | GO:0006163 | 146 | 0.021 | |
| regulation of cytoskeleton organization | GO:0051493 | 89 | 0.021 | Human |
| negative regulation of meiotic cell cycle | GO:0051447 | 2 | 0.021 | |
| positive regulation of hydrolase activity | GO:0051345 | 78 | 0.021 | |
| sex differentiation | GO:0007548 | 81 | 0.021 | |
| regulation of multicellular organismal development | GO:2000026 | 414 | 0.021 | |
| cellular response to radiation | GO:0071478 | 52 | 0.021 | |
| positive regulation of intracellular signal transduction | GO:1902533 | 116 | 0.021 | |
| protein dna complex assembly | GO:0065004 | 63 | 0.021 | |
| positive regulation of phosphate metabolic process | GO:0045937 | 139 | 0.020 | |
| positive regulation of cellular catabolic process | GO:0031331 | 95 | 0.020 | |
| cellular response to organic substance | GO:0071310 | 132 | 0.020 | |
| positive regulation of gene expression | GO:0010628 | 290 | 0.020 | |
| anion homeostasis | GO:0055081 | 3 | 0.020 | |
| chaeta morphogenesis | GO:0008407 | 42 | 0.019 | |
| compound eye photoreceptor cell differentiation | GO:0001751 | 140 | 0.019 | |
| positive regulation of mapk cascade | GO:0043410 | 63 | 0.019 | |
| nucleoside catabolic process | GO:0009164 | 112 | 0.019 | |
| protein complex assembly | GO:0006461 | 200 | 0.019 | |
| glycosyl compound catabolic process | GO:1901658 | 112 | 0.019 | |
| nucleotide metabolic process | GO:0009117 | 161 | 0.019 | |
| regulation of programmed cell death | GO:0043067 | 152 | 0.019 | |
| regulation of g2 m transition of mitotic cell cycle | GO:0010389 | 15 | 0.019 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 120 | 0.018 | |
| peptidyl amino acid modification | GO:0018193 | 105 | 0.018 | |
| embryo development ending in birth or egg hatching | GO:0009792 | 152 | 0.018 | |
| embryonic axis specification | GO:0000578 | 107 | 0.018 | |
| regulation of double strand break repair | GO:2000779 | 3 | 0.018 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 119 | 0.018 | |
| positive regulation of phosphorus metabolic process | GO:0010562 | 139 | 0.018 | |
| ribonucleotide catabolic process | GO:0009261 | 109 | 0.018 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 108 | 0.018 | |
| response to endogenous stimulus | GO:0009719 | 119 | 0.018 | |
| posttranscriptional gene silencing by rna | GO:0035194 | 45 | 0.017 | |
| phagocytosis | GO:0006909 | 215 | 0.017 | |
| regulation of mapk cascade | GO:0043408 | 92 | 0.017 | |
| response to oxygen containing compound | GO:1901700 | 200 | 0.017 | |
| purine nucleoside catabolic process | GO:0006152 | 112 | 0.017 | |
| positive regulation of cell cycle phase transition | GO:1901989 | 20 | 0.017 | |
| erbb signaling pathway | GO:0038127 | 58 | 0.017 | |
| glycosyl compound metabolic process | GO:1901657 | 127 | 0.017 | |
| regulation of erk1 and erk2 cascade | GO:0070372 | 39 | 0.017 | |
| chromosome organization involved in meiosis | GO:0070192 | 10 | 0.017 | |
| epidermal growth factor receptor signaling pathway | GO:0007173 | 58 | 0.017 | |
| ion transport | GO:0006811 | 145 | 0.017 | |
| dna alkylation | GO:0006305 | 4 | 0.017 | |
| negative regulation of protein metabolic process | GO:0051248 | 85 | 0.017 | Human |
| immune response | GO:0006955 | 246 | 0.016 | |
| organonitrogen compound catabolic process | GO:1901565 | 128 | 0.016 | |
| morphogenesis of follicular epithelium | GO:0016333 | 36 | 0.016 | |
| chromosome condensation | GO:0030261 | 41 | 0.016 | |
| positive regulation of mrna catabolic process | GO:0061014 | 5 | 0.016 | |
| pole plasm rna localization | GO:0007316 | 52 | 0.016 | |
| negative regulation of gene expression | GO:0010629 | 387 | 0.016 | Human |
| polyol biosynthetic process | GO:0046173 | 3 | 0.016 | |
| regulation of cellular response to stress | GO:0080135 | 89 | 0.016 | |
| regulation of cellular localization | GO:0060341 | 136 | 0.016 | |
| intracellular signal transduction | GO:0035556 | 300 | 0.016 | |
| response to decreased oxygen levels | GO:0036293 | 58 | 0.016 | |
| carbohydrate derivative catabolic process | GO:1901136 | 118 | 0.016 | |
| organophosphate catabolic process | GO:0046434 | 112 | 0.016 | |
| positive regulation of dna metabolic process | GO:0051054 | 12 | 0.016 | |
| regulation of ras protein signal transduction | GO:0046578 | 93 | 0.016 | |
| rna processing | GO:0006396 | 147 | 0.016 | |
| regulation of phosphate metabolic process | GO:0019220 | 210 | 0.015 | |
| rna interference | GO:0016246 | 27 | 0.015 | |
| segmentation | GO:0035282 | 207 | 0.015 | |
| macromolecular complex assembly | GO:0065003 | 256 | 0.015 | |
| regulation of mrna metabolic process | GO:1903311 | 72 | 0.015 | |
| male pronucleus assembly | GO:0035039 | 6 | 0.015 | |
| cell cycle arrest | GO:0007050 | 4 | 0.015 | |
| purine ribonucleotide metabolic process | GO:0009150 | 145 | 0.015 | |
| negative regulation of organelle organization | GO:0010639 | 56 | 0.015 | Human |
| aging | GO:0007568 | 143 | 0.015 | |
| determination of adult lifespan | GO:0008340 | 137 | 0.015 | |
| purine ribonucleotide catabolic process | GO:0009154 | 109 | 0.014 | |
| establishment or maintenance of cell polarity | GO:0007163 | 167 | 0.014 | |
| dna biosynthetic process | GO:0071897 | 24 | 0.014 | |
| spermatid development | GO:0007286 | 98 | 0.014 | |
| regulation of cellular protein metabolic process | GO:0032268 | 243 | 0.014 | Human |
| tissue morphogenesis | GO:0048729 | 297 | 0.014 | |
| anatomical structure homeostasis | GO:0060249 | 97 | 0.014 | |
| cell motility | GO:0048870 | 251 | 0.014 | |
| negative regulation of signaling | GO:0023057 | 219 | 0.014 | |
| regulation of catalytic activity | GO:0050790 | 185 | 0.014 | |
| positive regulation of molecular function | GO:0044093 | 136 | 0.014 | |
| cellular protein modification process | GO:0006464 | 438 | 0.014 | |
| regulation of response to dna damage stimulus | GO:2001020 | 23 | 0.014 | |
| ribonucleotide metabolic process | GO:0009259 | 145 | 0.013 | |
| nucleoside monophosphate metabolic process | GO:0009123 | 52 | 0.013 | |
| histone acetylation | GO:0016573 | 38 | 0.013 | |
| carboxylic acid metabolic process | GO:0019752 | 92 | 0.013 | |
| negative regulation of transcription dna templated | GO:0045892 | 237 | 0.013 | |
| translesion synthesis | GO:0019985 | 2 | 0.013 | |
| positive regulation of protein metabolic process | GO:0051247 | 128 | 0.013 | |
| nucleotide catabolic process | GO:0009166 | 109 | 0.013 | |
| positive regulation of catalytic activity | GO:0043085 | 118 | 0.013 | |
| positive regulation of phosphorylation | GO:0042327 | 87 | 0.013 | |
| negative regulation of biosynthetic process | GO:0009890 | 277 | 0.013 | |
| appendage morphogenesis | GO:0035107 | 397 | 0.013 | |
| cell aging | GO:0007569 | 2 | 0.013 | |
| establishment of protein localization | GO:0045184 | 163 | 0.013 | |
| mrna metabolic process | GO:0016071 | 124 | 0.013 | |
| regulation of apoptotic process | GO:0042981 | 130 | 0.013 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 119 | 0.012 | |
| cell proliferation | GO:0008283 | 299 | 0.012 | |
| negative regulation of growth | GO:0045926 | 84 | 0.012 | |
| mapk cascade | GO:0000165 | 107 | 0.012 | |
| regulation of phosphorylation | GO:0042325 | 147 | 0.012 | |
| anterior posterior axis specification embryo | GO:0008595 | 103 | 0.012 | |
| regulation of cellular catabolic process | GO:0031329 | 157 | 0.012 | Human |
| reproductive system development | GO:0061458 | 74 | 0.012 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 57 | 0.012 | |
| locomotory behavior | GO:0007626 | 176 | 0.012 | |
| negative regulation of nucleobase containing compound metabolic process | GO:0045934 | 261 | 0.012 | |
| protein complex biogenesis | GO:0070271 | 201 | 0.012 | |
| dna replication | GO:0006260 | 48 | 0.012 | |
| male meiosis i | GO:0007141 | 9 | 0.012 | |
| response to organophosphorus | GO:0046683 | 2 | 0.012 | |
| response to oxygen levels | GO:0070482 | 59 | 0.012 | |
| secondary metabolite catabolic process | GO:0090487 | 1 | 0.012 | |
| negative regulation of macromolecule biosynthetic process | GO:0010558 | 270 | 0.012 | |
| dna dependent dna replication | GO:0006261 | 17 | 0.012 | |
| imaginal disc derived appendage development | GO:0048737 | 399 | 0.011 | |
| developmental growth | GO:0048589 | 280 | 0.011 | |
| dna templated transcriptional preinitiation complex assembly | GO:0070897 | 20 | 0.011 | |
| postreplication repair | GO:0006301 | 2 | 0.011 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 85 | 0.011 | Human |
| establishment or maintenance of polarity of follicular epithelium | GO:0016334 | 26 | 0.011 | |
| positive regulation of nuclear transcribed mrna catabolic process deadenylation dependent decay | GO:1900153 | 4 | 0.011 | |
| growth | GO:0040007 | 359 | 0.011 | |
| purine ribonucleoside monophosphate catabolic process | GO:0009169 | 38 | 0.011 | |
| striated muscle cell differentiation | GO:0051146 | 90 | 0.011 | |
| meiotic sister chromatid cohesion | GO:0051177 | 6 | 0.011 | |
| positive regulation of developmental process | GO:0051094 | 143 | 0.011 | |
| positive regulation of g2 m transition of mitotic cell cycle | GO:0010971 | 2 | 0.011 | |
| neurological system process | GO:0050877 | 358 | 0.011 | |
| signal transduction in response to dna damage | GO:0042770 | 3 | 0.011 | |
| regulation of mrna processing | GO:0050684 | 71 | 0.011 | |
| positive regulation of cell development | GO:0010720 | 61 | 0.011 | |
| positive regulation of cell communication | GO:0010647 | 250 | 0.011 | |
| positive regulation of nucleic acid templated transcription | GO:1903508 | 266 | 0.011 | |
| telomere maintenance | GO:0000723 | 21 | 0.011 | |
| response to uv | GO:0009411 | 24 | 0.011 | |
| immune response regulating signaling pathway | GO:0002764 | 2 | 0.011 | |
| positive regulation of multicellular organismal process | GO:0051240 | 143 | 0.011 | |
| protein localization | GO:0008104 | 284 | 0.011 | |
| response to inorganic substance | GO:0010035 | 44 | 0.011 | |
| oxoacid metabolic process | GO:0043436 | 103 | 0.011 | |
| tripartite regional subdivision | GO:0007351 | 103 | 0.011 | |
| spinal cord patterning | GO:0021511 | 1 | 0.011 | |
| ribonucleoside monophosphate catabolic process | GO:0009158 | 39 | 0.010 | |
| regulation of growth | GO:0040008 | 233 | 0.010 | |
| regulation of cell morphogenesis | GO:0022604 | 163 | 0.010 | |
| purine nucleotide catabolic process | GO:0006195 | 109 | 0.010 | |
| cellular response to ionizing radiation | GO:0071479 | 15 | 0.010 | |
| positive regulation of cellular protein metabolic process | GO:0032270 | 118 | 0.010 | |
| positive regulation of ras protein signal transduction | GO:0046579 | 43 | 0.010 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 108 | 0.010 | |
| synaptic transmission | GO:0007268 | 288 | 0.010 | |
| response to other organism | GO:0051707 | 293 | 0.010 | |
| female germ line cyst formation | GO:0048135 | 42 | 0.010 | |